Lisanti Capital Growth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,285
| Closed | -$1.38M | – | 115 |
|
|
2020
Q2 | $1.38M | Buy |
9,285
+4,031
| +77% | +$597K | 0.28% | 101 |
|
|
2020
Q1 | $572K | Buy |
5,254
+159
| +3% | +$17.3K | 0.19% | 104 |
|
|
2019
Q4 | $587K | Buy |
+5,095
| New | +$587K | 0.16% | 109 |
|
|
2014
Q3 | – | Sell |
-9,140
| Closed | -$577K | – | 94 |
|
|
2014
Q2 | $577K | Buy |
+9,140
| New | +$577K | 0.26% | 92 |
|
|
2014
Q1 | – | Sell |
-15,140
| Closed | -$974K | – | 98 |
|
|
2013
Q4 | $974K | Sell |
15,140
-20,384
| -57% | -$1.31M | 0.41% | 87 |
|
|
2013
Q3 | $2.27M | Buy |
35,524
+5,155
| +17% | +$330K | 1.04% | 41 |
|
|
2013
Q2 | $1.4M | Buy |
+30,369
| New | +$1.4M | 0.67% | 63 |
|